Alpha Tribe
FeedCompaniesAgentsSubscribe

Filter announcements

  • All
  • Important
  • Results
  • Board Meeting
  • New Orders
  • QIP/Rights/Pref.
  • PPTs
  • JV/Acquisition
  • Insider Trade
  • Dividend/Bonus
  • Credit Ratings
  • Updates
  • Pledging
  • Investor Meet
  • Others

Download our app

Best experience on mobile

Get it on Google PlayDownload on the App Store

Join 5K+ users on Alpha Tribe

Loading...
Epigral Limited logo

Epigral Limited

EPIGRAL·Chemicals

Epigral Limited, formerly known as Meghmani Finechem Ltd, incorporated in 2007, is a leading integrated manufacturer of chemicals in India. Epigral’s Dahej facility is a backward and forward integrated and automated complex with a well-planned infrastructure.

175Announcements
31-08-2026Last filed
18Last 90 days

What Epigral files

  • Investor Meet72
  • Others48
  • Important15
  • Updates13
  • Board Meeting9
  • PPTs7
31-08-2026 · 05:47 pm

Epigral Limited will host an Investor / Analyst Plant Visit for Bellwether Capital at its Dahej, Gujarat facility on Thursday, 3rd September, 2026. No unpublished price sensitive information will be shared during this visit.

Read the full announcement→
PDF
18-08-2026 · 06:39 pm

Epigral Limited will hold a One-on-One meeting with Incred Research Services Pvt. Ltd. on Thursday, August 20, 2026, in Ahmedabad. The company's latest Earnings and Corporate Presentations, already publicly available, may be discussed. No unpublished price sensitive information will be shared.

Read the full announcement→
PDF
07-08-2026 · 04:56 pm

Epigral Limited officials will participate in the EMKAY Confluence 2026, a conference taking place in Mumbai.

Read the full announcement→
PDF
30-07-2026 · 07:36 pm

Epigral Limited is scheduled for a one-on-one meeting with VVD Asset Managers in Ahmedabad. Discussions will refer to the latest Earnings and Corporate Presentations, available on the company website. No unpublished price sensitive information will be shared.

Read the full announcement→
PDF
30-07-2026 · 07:31 pm

Epigral reported Q1 FY27 revenue up 15% YoY to INR 709 Cr and PAT up 25% to INR 99 Cr, despite a challenging quarter. The company announced a strategic INR 600 Cr capex for Epoxy Resin & Formulations (125,000 TPA) and a Multipurpose Plant for downstream ECH/chlorotoluenes derivatives. This forward...

Read the full announcement→
PDF